In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Guidant buys CTS for $313mm in stock

Executive Summary

Guidant is buying minimally invasive surgical company CardioThoracic Systems in a stock swap that values CTS common shares at $19.50 each, a slight premium ((pr)2%) to its 10-day pre-announcement price. The transaction values CTS at $313mm, and will be accounted for as a pooling of interest. Although the premium is small, CTS's stock is trading at its highest price in several years. It went public in 1996 at $18, but last September its shares were trading in the $3-4 range, and have steadily increased since then.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies